Dr. Mark David Mifflin, MD

Dr. Mifflin practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Mifflin's NPI, 1548350150, was assigned on October 13, 2006. Dr. Mifflin graduated from University of Nevada School of Medicine in 1990. Dr. Mifflin holds Utah license 185327-1205.

Dr. Mifflin's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Mifflin's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Mifflin is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Mifflin to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mifflin practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Mifflin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Mifflin is licensed in Utah.

CMS data shows 908 Medicare services from Dr. Mifflin across 14 procedure codes in 2024, for 438 Medicare patients. Medicare paid $89,967 for them.

CMS counts 438 Medicare patients who saw Dr. Mifflin in 2024. The largest group is 75 to 84, with 184 patients. 65% of them have high blood pressure, and 61% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mifflin's median patient age at 74, with 55% women.

In 2024, Dr. Mifflin wrote 1,303 Medicare Part D claims for 403 patients. 51% of them were for generic drugs. CMS names the drug for 1,215 of them, across 17 drugs with 11 or more claims each, at $64,964 in total drug cost. In 2023, CMS named 1,164 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Mifflin for performance year 2024, reported as part of a group. Dr. Mifflin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 217 procedures of cataract surgery by Dr. Mifflin, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 42 papers to Dr. Mifflin, published from 2011 to 2024. 2012 was the busiest year, with 4. The most frequent topics are Visual Acuity, Descemet Stripping Endothelial Keratoplasty and Corneal Diseases. Dr. Mifflin has published most often in Cornea. Dr. Mifflin's most frequent co-authors are Brent S. Betts, MD, Maylon Hsu, MD and Nick Mamalis, MD.

CMS Open Payments shows 12 general payments to Dr. Mifflin from 6 drug and device companies from 2016 to 2025. Charitable contributions make up the largest share, 99% of the total. Valeant Pharmaceuticals International paid the most, $27,671.

Dr. Mifflin graduated from University of Nevada School of Medicine in 1990.